Global Onychomycosis (Tinea Unguium) Drug Market 2012- 2022

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

1.1.2 Specifications

1.2 Market Segment

1.2.1 by Product

1.2.1.1 Oral

1.2.1.2 External

1.2.2 by Application

1.2.2.1 Age under 18

1.2.2.2 Age 18-50

1.2.2.3 Age above 50

1.2.3 by Regions

1.2.3.1 Europe

1.2.3.2 North America

1.2.3.3 China

1.2.3.4 Korea & Japan

2 Industry Chain

2.1 Industry Chain Structure

2.2 Upstream

2.2.1 Raw Material

2.2.2 Major Equipment

2.2.3 Manufacturing Cost Structure

2.2.4 Manufacturing Process

2.3 Market

2.3.1 SWOT

2.3.2 Dynamics

3 Environmental Analysis

3.1 Policy

3.2 Economic

3.3 Technology

3.4 Market Entry

4 Major Vendors

4.1 Johnson & Johnson

4.1.1 Profile

4.1.2 Business Performance

4.2 GSK

4.2.1 Profile

4.2.2 Business Performance

4.3 Novartis

4.3.1 Profile

4.3.2 Business Performance

4.4 Pfizer

4.4.1 Profile

4.4.2 Business Performance

4.5 Valeant Pharma

4.5.1 Profile

4.5.2 Business Performance

4.6 Kaken Pharmaceutical

4.6.1 Profile

4.6.2 Business Performance

4.7 Galderma

4.7.1 Profile

4.7.2 Business Performance

4.8 Xiuzheng Pharmaceutical

4.8.1 Profile

4.8.2 Business Performance

4.9 Letai

4.9.1 Profile

4.9.2 Business Performance

4.10 Qilu Pharmaceutical

4.10.1 Profile

4.10.2 Business Performance

5 Market/Vendors Distribution

5.1 Regional Distribution

5.1.1 Headquarters

5.1.2 Sales Region

5.2 Product and Application

5.2.1 Product

5.2.2 Application

6 Regions Market

6.1 Global

6.1.1 Overview

6.1.2 by Vendors

6.1.3 by Products

6.1.4 by Application

6.1.5 by Regions

6.2 Europe

6.2.1 Overview

6.2.2 by Vendors

6.2.3 by Products

6.2.4 by Application

6.2.5 by Regions

6.3 North America

6.3.1 Overview

6.3.2 by Vendors

6.3.3 by Products

6.3.4 by Application

6.3.5 by Regions

6.4 China

6.4.1 Overview

6.4.2 by Vendors

6.4.3 by Products

6.4.4 by Application

6.4.5 by Regions

6.5 Korea & Japan

6.5.1 Overview

6.5.2 by Vendors

6.5.3 by Products

6.5.4 by Application

6.5.5 by Regions

6.6 Trade

7 Forecast

7.1 Market Trends

7.2 Segment Forecast

7.2.1 by Products

7.2.2 by Application

7.2.3 by Regions

8 Marketing Overview

8.1 Ex-factory Price

8.2 Buyer Price

8.3 Price Factors

8.4 Marketing Channel

9 Conclusion

List Of Tables
Table Product Specifications of Onychomycosis (Tinea Unguium) Drug

Table Products Segment of Onychomycosis (Tinea Unguium) Drug

Table Oral Overview

Table External Overview

Table Application Segment of Onychomycosis (Tinea Unguium) Drug

Table Age under 18 Overview

Table Age 18-50 Overview

Table Age above 50 Overview

Table Raw Material Suppliers Analysis

Table Equipment Suppliers Analysis

Table Market Dynamics

Table Policy of Onychomycosis (Tinea Unguium) Drug

Table Technology of Onychomycosis (Tinea Unguium) Drug

Table Johnson & Johnson Profile List

Table Onychomycosis (Tinea Unguium) Drug Operating Data of Johnson & Johnson,2012-2016 (USD Million)

Table GSK Profile List

Table Onychomycosis (Tinea Unguium) Drug Operating Data of GSK,2012-2016 (USD Million)

Table Novartis Profile List

Table Onychomycosis (Tinea Unguium) Drug Operating Data of Novartis,2012-2016 (USD Million)

Table Pfizer Profile List

Table Onychomycosis (Tinea Unguium) Drug Operating Data of Pfizer,2012-2016 (USD Million)

Table Valeant Pharma Profile List

Table Onychomycosis (Tinea Unguium) Drug Operating Data of Valeant Pharma,2012-2016 (USD Million)

Table Kaken Pharmaceutical Profile List

Table Onychomycosis (Tinea Unguium) Drug Operating Data of Kaken Pharmaceutical,2012-2016 (USD Million)

Table Galderma Profile List

Table Onychomycosis (Tinea Unguium) Drug Operating Data of Galderma,2012-2016 (USD Million)

Table Xiuzheng Pharmaceutical Profile List

Table Onychomycosis (Tinea Unguium) Drug Operating Data of Xiuzheng Pharmaceutical,2012-2016 (USD Million)

Table Letai Profile List

Table Onychomycosis (Tinea Unguium) Drug Operating Data of Letai,2012-2016 (USD Million)

Table Qilu Pharmaceutical Profile List

Table Onychomycosis (Tinea Unguium) Drug Operating Data of Qilu Pharmaceutical,2012-2016 (USD Million)

Table Headquarters of Major Vendors

Table Main Sales Region of Major Vendors

Table Main Product of Major Vendors

Table Main Application of Major Vendors

Table Onychomycosis (Tinea Unguium) Drug Price of Global

Table Onychomycosis (Tinea Unguium) Drug Price of Europe

Table Onychomycosis (Tinea Unguium) Drug Price of North America

Table Onychomycosis (Tinea Unguium) Drug Price of China

Table Onychomycosis (Tinea Unguium) Drug Price of Korea & Japan

Table Global Sales Forecast, by Products, (2017-2022, Million USD)

Table Global Sales Forecast, by Application, (2017-2022, Million USD)

Table Global Sales Forecast, by Regions, (2017-2022, Million USD)

Table Price Factors List

Table Part of Interviewees List

Table Part of Source List

Table Methodology of HeyReport Overview

List Of Figures
Figure Onychomycosis (Tinea Unguium) Drug Picture

Figure Oral Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure External Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Age under 18 Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Age 18-50 Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Age above 50 Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure China Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Korea & Japan Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Industry Chain Structure of Onychomycosis (Tinea Unguium) Drug

Figure Manufacturing Process of Onychomycosis (Tinea Unguium) Drug

Figure SWOT of Onychomycosis (Tinea Unguium) Drug

Figure GDP of Major Countries

Figure Onychomycosis (Tinea Unguium) Drug Sales and Growth of Global, 2012-2016 (USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of Global, by Vendors (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of Global, by Products (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of Global, by Application (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of Global, by Regions (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales and Growth of Europe, 2012-2016 (USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of Europe, by Vendors (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of Europe, by Products (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of Europe, by Application (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales and Growth of North America, 2012-2016 (USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of North America, by Vendors (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of North America, by Products (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of North America, by Application (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales and Growth of China, 2012-2016 (USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of China, by Vendors (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of China, by Products (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of China, by Application (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales and Growth of Korea & Japan, 2012-2016 (USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of Korea & Japan, by Vendors (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of Korea & Japan, by Products (2016, USD Million)

Figure Onychomycosis (Tinea Unguium) Drug Sales of Korea & Japan, by Application (2016, USD Million)

Figure World Trade Flows

Figure Global Sales Forecast and Growth, (2017-2022, Million USD)

Figure Marketing Channels Overview